Trial Profile

A retrospective survey for capturing the treatment experiences of adults with spasticity who treated with Botulinum Toxin Type A

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 24 Nov 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Botulinum-Toxin-A (Primary)
Indications Muscle spasticity
Focus Therapeutic Use

Most Recent Events

19 Nov 2020 Results assessing impact of spasticity and the impact of symptom re-emergence on patients' employment, comparing results from the United States (US) versus Europe (EU), presented at the 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research.
26 May 2020 Results (n=209) presented at the 6th Congress of the European Academy of Neurology
26 May 2020 Results presented at the 6th Congress of the European Academy of Neurology

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com